omega-n-methylarginine has been researched along with ketorolac in 9 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (ketorolac) | Trials (ketorolac) | Recent Studies (post-2010) (ketorolac) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 1,778 | 668 | 725 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | ketorolac (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.013 | |
| Caspase-1 | Homo sapiens (human) | 1.3025 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.282 | |
| Caspase-3 | Homo sapiens (human) | 1.3025 | |
| Caspase-4 | Homo sapiens (human) | 1.3025 | |
| Caspase-5 | Homo sapiens (human) | 1.3025 | |
| Caspase-9 | Homo sapiens (human) | 1.3025 | |
| Cell division control protein 42 homolog | Homo sapiens (human) | 2 | |
| Ras-related C3 botulinum toxin substrate 1 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelazeem, AH; Khan, SI; McCurdy, CR; Sufka, KJ; White, SW | 1 |
| Casey, DP; Joyner, MJ | 1 |
| Augeri, AL; Kiernan, FJ; Parker, BA; Polk, DM; Thompson, PD; Tschakovsky, ME | 1 |
| Crecelius, AR; Dinenno, FA; Kirby, BS; Larson, DG; Luckasen, GJ | 1 |
| Casey, DP; Joyner, MJ; Lopez, MG; Silva, BM | 1 |
| Eldridge, MW; Harrell, JW; Johansson, RE; Kellawan, JM; Schrage, WG; Sebranek, JJ; Walker, BJ | 1 |
| Crecelius, AR; Dinenno, FA; Hearon, CM; Kirby, BS; Larson, DG; Luckasen, GJ | 1 |
| Eldridge, MW; Harrell, JW; Johansson, RE; Kellawan, JM; Limberg, JK; Peltonen, GL; Schrage, WG; Sebranek, JJ | 1 |
| Carter, KJ; Eldridge, MW; Harrell, JW; Johansson, RE; Kellawan, JM; Limberg, JK; Peltonen, GL; Schrage, WG; Sebranek, JJ; Walker, BJ | 1 |
3 trial(s) available for omega-n-methylarginine and ketorolac
| Article | Year |
|---|---|
ATP-mediated vasodilatation occurs via activation of inwardly rectifying potassium channels in humans.
Topics: Acetylcholine; Adenosine Triphosphate; Adult; Barium Compounds; Chlorides; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Humans; Ketorolac; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Ouabain; Potassium Channels, Inwardly Rectifying; Potassium Chloride; Sodium-Potassium-Exchanging ATPase; Vasodilation; Vasodilator Agents; Young Adult | 2012 |
Roles of nitric oxide and prostaglandins in the hyperemic response to a maximal metabolic stimulus: redundancy prevails.
Topics: Blood Pressure; Enzyme Inhibitors; Exercise; Female; Forearm; Hand Strength; Humans; Hyperemia; Ischemia; Ketorolac; Male; Nitric Oxide; omega-N-Methylarginine; Prostaglandins; Regional Blood Flow; Young Adult | 2013 |
Contracting human skeletal muscle maintains the ability to blunt α1 -adrenergic vasoconstriction during KIR channel and Na(+) /K(+) -ATPase inhibition.
Topics: Adenosine; Adult; Barium Compounds; Brachial Artery; Chlorides; Exercise; Female; Forearm; Hand Strength; Humans; Ketorolac; Male; Muscle Contraction; Muscle, Skeletal; omega-N-Methylarginine; Ouabain; Potassium Channels, Inwardly Rectifying; Propranolol; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Sodium-Potassium-Exchanging ATPase; Vasoconstriction; Young Adult | 2015 |
6 other study(ies) available for omega-n-methylarginine and ketorolac
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of bivalent benzoxazolone and benzothiazolone ligands as potential anti-inflammatory/analgesic agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzothiazoles; Benzoxazoles; Carrageenan; Cell Line, Tumor; Chlorocebus aethiops; Dimerization; Drug Design; Edema; Epithelial Cells; Hindlimb; Humans; Kidney; Macrophages; Mice; Molecular Docking Simulation; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Structure-Activity Relationship; Swine; Vero Cells | 2015 |
Prostaglandins do not contribute to the nitric oxide-mediated compensatory vasodilation in hypoperfused exercising muscle.
Topics: Acetylcholine; Blood Pressure; Brachial Artery; Catheterization; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Exercise; Forearm; Heart Rate; Humans; Hyperemia; Ketorolac; Male; Muscle, Skeletal; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandins; Regional Blood Flow; Vasodilation; Vasodilator Agents; Vital Capacity; Young Adult | 2011 |
Heterogenous vasodilator pathways underlie flow-mediated dilation in men and women.
Topics: Adult; Analysis of Variance; Blood Flow Velocity; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Humans; Hyperemia; Infusions, Intra-Arterial; Ketorolac; Laser-Doppler Flowmetry; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Radial Artery; Regional Blood Flow; Sex Factors; Ultrasonography; Vasodilation; Vasodilator Agents; Young Adult | 2011 |
Exercise vasodilation is greater in women: contributions of nitric oxide synthase and cyclooxygenase.
Topics: Adolescent; Adult; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Exercise; Female; Forearm; Hemodynamics; Humans; Ketorolac; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Regional Blood Flow; Sex Characteristics; Ultrasonography; Vascular Resistance; Vasodilation; Young Adult | 2015 |
β-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase.
Topics: Adrenergic beta-Agonists; Adult; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Forearm; Humans; Infusions, Intra-Arterial; Isoproterenol; Ketorolac; Male; Microcirculation; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Sex Factors; Ultrasonography, Doppler; Vasodilation | 2016 |
Preserved β-adrenergic-mediated vasodilation in skeletal muscle of young adults with obesity despite shifts in cyclooxygenase and nitric oxide synthase.
Topics: Adrenergic beta-Agonists; Adult; Blood Vessels; Cyclooxygenase Inhibitors; Female; Humans; Isoproterenol; Ketorolac; Male; Muscle, Skeletal; Nitric Oxide Synthase Type III; Obesity; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Receptors, Adrenergic, beta; Vasodilation | 2022 |